v3.26.1
Condensed Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (2,174,836) $ (764,577)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 12,306 17,825
Stock based compensation 128,440 129,650
Amortization of license fees 5,625 5,625
Amortization of right-of-use assets, net of liabilities (3,120) (1,838)
Amortization of debt discount 240,370  
Issuance of shares for services 100,000
Change in fair value of derivative liability 148,766
Loss on issuance of convertible note 322,359
Changes in operating assets and liabilities:    
Accounts receivable (1,527) 5,610
Inventory 11,694 (20,866)
Prepaid expenses and other assets (46,199) (64,259)
Accounts payable 111,941 111,092
Accrued liabilities (202,448) 129,413
Interest payable 26,634 740
Deferred revenue 31,035 (36,708)
Net cash used in operating activities (1,288,960) (488,293)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Purchases of intangible assets, including patents (5,354)
Net cash used in investing activities (5,354)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from issuance of convertible notes payable 250,000 70,000
Proceeds from issuance of Series D preferred stock 192,338
Proceeds from issuance of Series E preferred stock 5,000,000
Offering costs (762,574)
Net cash provided by financing activities 4,487,426 262,338
Increase (decrease) in cash and cash equivalents 3,193,112 (225,955)
Cash and cash equivalents, beginning of year 1,025,987 1,784,009
Cash and cash equivalents, end of year 4,219,099 1,558,054
Supplemental disclosures of cash flow information:    
Cash paid for interest
Cash paid for income taxes
Non-cash disclosures of cash flow information:    
Conversion of preferred stock to common stock 47,174
Deferred offering costs – issuance of common stock issued as offering costs 3,654,057
Accrued dividends on Series E preferred stock 54,192
Derivative liabilities recognized as debt discounts 541,199
Derivative liabilities reclassified to equity 1,361,306
Conversion of convertible notes payable and accrued interest to common stock $ 834,812